相关实验视频
Updated: Jun 29, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
为胰岛素治疗糖尿病患者制定糖尿病出院顺序.
Elizabeth Miles1, Melissa McKnight2, Claire C Schmitz3
1Division of Hospital Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Journal of diabetes science and technology
|March 28, 2024
概括
实施胰岛素释放订单,为糖尿病患者改善了供应订单. 虽然它没有改变胰岛素治疗方案的强化,但该命令为提供必要的物资和教育提供了帮助,以改善出院后的护理.
科学领域:
- 内部医学 内部医学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰岛素是一种高风险的药物,经常与处方错误有关.
- 糖尿病患者因药物错误而面临更高的住院率和长时间住院.
- 常见的胰岛素处方错误包括缺失的订单,错误的胰岛素类型和不充分的疗程强化.
研究的目的:
- 探索基于系统的干预措施和教育工具,以减少胰岛素处方错误.
- 为改善糖尿病患者胰岛素释放方案的质量.
主要方法:
- 进行了需求评估和基线图的审查.
- 在beta测试后,调整并实施了一套糖尿病出院顺序.
- 干预后的图表审查评估了订单设置的影响.
主要成果:
- 98%的提供者希望设置胰岛素释放顺序.
- 订单集的高利用率使所有必要供应的订购率从27%提高到55%.
- 在失控糖尿病患者在出院时加强胰岛素治疗方案时没有观察到任何显著变化.
结论:
- 糖尿病出院订单可以提高出院时提供必需胰岛素的供应.
- 订单组有可能改善患者教育,并促进适当的胰岛素治疗方案.
- 可能需要进一步的干预措施来解决在出院时胰岛素疗程的强化问题.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Discharge Summary Forms
754
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
754
Insulin Formulations: Types and Delivery
193
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
193
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K

